|
|
Memantine for dementia
... Sastre A, Minakaran N. Memantine for dementia. ... of efficacy of memantine for dementia ... randomized trials of memantine in people with dementia. ...
Information about Dementia at memantine.com
Memantine.com | Dementia: Here you get information about forms of diseases, drugs, therapies, care and latest research results.
Treatments for Dementia & Memantine - DementiaGuide.com - DementiaGuide.com
Memantine goes by several trade names including Ebixa, Nameda and Axura. ... for Dementia. Cholinesterase Inhibitors. Memantine. Neuroleptics ...
memantine (Namenda) - drug class, medical uses, medication side effects ...
Specifies the medication memantine (Namenda), a drug used for the treatment of moderate to severe dementia of the Alzheimer's type.
Memantine - Wikipedia, the free encyclopedia
Memantine is also being tested for opioid dependence, systemic lupus ... Memantine for dementia". Cochrane Database Syst Rev (3): CD003154. ...
Information about Vascular Dementia at memantine.com
Memantine.com | Vascular Dementia: Here you get information about forms of diseases, drugs, therapies, care and latest research results.
THE MERCK MANUAL OF GERIATRICS, Ch. 40, Dementia
Overview and fact sheet on dementia from the Merck Medical Manual. ... Memantine, an NMDA (N-methyl-D-aspartate) antagonist, may help defer progression ...
Buy Memantine (Ebixa) - Optimal Health Products
Buy Memantine (Ebixa) online - 50 x 10 mg tablets Memantine - brand name Ebixa is a novel new drug that is showing a lot ... dementia), Memantine has been ...
MEMANTINE - ORAL (Namenda) side effects, medical uses, and drug ...
Read more about the prescription drug MEMANTINE - ORAL. ... Read 15 more memantine related articles ... Groups Issue New Dementia Drug Guidelines ...
Memantine
Memantine is used for patients who already have moderate to ... Memantine Helped Variety of Dementias: In a 12- week DB PC study ... Memantine for dementia ...
|
|
|
|
Dementia memantine |
New Approaches to Clinical Trials in Vascular Dementia: Memantine in Small Vessel DiseaseAlthough criteria for the diagnosis of vascular dementia (VaD) are established, the diagnostic concept is still controversial and there is no regulatory guidance for clinical drug development. Clinical trials in VaD present a number of pitfalls and challenges and, so far, no compound has received regulatory approval for this indication. The methodological issues of clinical VaD trials are discussed using the development of memantine for this indication as an example. In a pooled analysis of two placebo-controlled trials with the NMDA-antagonist memantine in VaD, the cognitive benefit by memantine treatment was more pronounced for patients with 'small vessel disease' than for those with other neuroradiological findings at baseline. In a subgroup of patients with 'large vessel disease' or macrolesions, there was less cognitive decline among the placebo patients.
|
Rating: 3.5 из 5 (голосов: 151) |
|
19 october 2008
Иван Кузнецов
|
|
|
|
|
memantine dementia
memantine depression
memantine in alzheimer's
memantine mode of action
|
|
|
|
|
CATIE-AD: Atypical Antipsychotics Linked to Weight Gain in Older Women
Medscape - Apr 23, 2009
At randomization, 46% were using antihypertensive agents, 60% were taking a cholinesterase inhibitor or memantine, 24% were on cholesterol-lowering ...
Non-drug Treatment Of Alzheimer's Disease? Long-term Benefit Not ...
Science Daily (press release) - Apr 15, 2009
None of the 33 studies compared a non-drug intervention with a drug intervention assessed by IQWiG (cholinesterase inhibitors, ginkgo compounds, memantine). ...
Aging brain to be focus of April 20 lecture at MSU
Montana State University - Apr 9, 2009
His lab developed the first glutamate receptor/channel antagonist drug (Memantine) to be clinically approved for dementia. His lab also studies the cloning ...
|
|
|
|
|